Deadlines for submission of applications for orphan medicinal product designation to the EMA and corresponding COMP timetable for valid applications - 2024-2025

Deadlines for submission of applications for orphan medicinal product designation to the EMA and corresponding COMP timetable for valid applications - 2024-2025

Annex to interim measures regarding notification of pharmacovigilance alerts by marketing authorisation holders under Regulation (EU) 2019/6: contact points

Annex to interim measures regarding notification of pharmacovigilance alerts by marketing authorisation holders under Regulation (EU) 2019/6: contact points

Human medicines European public assessment report (EPAR): Stalevo, levodopa,carbidopa,entacapone, Date of authorisation: 17/10/2003, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Stalevo, levodopa,carbidopa,entacapone, Date of authorisation: 17/10/2003, Revision: 30, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.